The effect of nimodipine on calcium homeostasis and pain sensitivity in diabetic rats

Cellular and Molecular Neurobiology

Volumn 26, Issue 7-8, 2006, Pages 1541-1557

  Shutov, L ^a   Kruglikov, I ^a   Gryshchenko, O ^a   Khomula, E ^b   Viatchenko Karpinski, V ^a   Belan, P ^a   Voitenko, N ^a  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b International Center of Molecular Physiology   (Ukraine)

Author keywords

Calcium; Dorsal horn neurons; Dorsal root ganglion; Enalapril; Endoplasmic reticulum; Nimodipine

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; ENALAPRIL; FORMALDEHYDE; NIMODIPINE; STREPTOZOCIN; VASODILATOR AGENT;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ENDOPLASMIC RETICULUM; FLUORESCENCE; HYPOALGESIA; MALE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPINAL CORD; SPINAL GANGLION; STIMULUS RESPONSE; STREPTOZOCIN DIABETES; SUBSTANTIA GELATINOSA; VASODILATATION;

ANIMALS; BEHAVIOR, ANIMAL; CALCIUM; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DRUG EVALUATION, PRECLINICAL; HOMEOSTASIS; MALE; NEURONS, AFFERENT; NIMODIPINE; PAIN THRESHOLD; RATS; RATS, WISTAR;

EID: 33845542153     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-006-9107-z     Document Type: Article

References (52)

1. Agrawal, R., Marx, A., and Haller, H. (2006). Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. J. Hypertens. 24:185-192.
2. Biessels, G., and Gispen, W. H. (1996). The calcium hypothesis of brain aging and neurodegenerative disorders: significance in diabetic neuropathy. Life Sci. 59:379-387.
3. Biessels, G. J., ter Laak, M. P., Hamers, F. P., and Gispen, W. H. (2002). Neuronal Ca(2+) disregulation in diabetes mellitus. Eur. J. Pharmacol. 447:201-209.
4. 2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocindiabetic rats. Brain Res. 1035:86-93.
5. Bliss, T. V., and Collingridge, G. L. (1993). A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361:31-39.
6. Bowersox, S. S., Gadbois, T., Singh, T., Pettus, M., Wang, Y. X., and Luther, R. R. (1996). Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J. Pharmacol. Exp. Ther. 279:1243-1249.
7. Brewster, W. J., Fernyhough, P., Diemel, L. T., Mohiuddin, L., and Tomlinson, D. R. (1995). Changes in nerve growth factor and preprotachykinin messenger RNA levels in the iris and trigeminal ganglion in diabetic rats: Effects of treatment with insulin or nerve growth factor. Mol. Brain Res. 29:131-139.
8. Calcutt, N. A., Freshwater, J. D., and Mizisin, A. P. (2004). Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47:718-724.
9. Cameron, N. E., and Cotter, M. A. (1994). The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab. Rev. 10:189-224.
10. Coderre, T. J., Vaccarino, A. L., and Melzack, R. (1990). Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res. 535:155-158.
11. Coppey, L. J., Davidson, E. P., Rinehart, T. W., Gellett, J. S., Oltman, C. L., Lund, D. D., and Yorek, M. A. (2006). ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 55:341-348.
12. Finkel, T., and Holbrook, N. J. (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408:239-247.
13. Gispen, W. H., and Hamers, F. P. (1994). Calcium and neuronal dysfunction in peripheral nervous system. Ann. N. Y. Acad. Sci. 747:419-430.
14. Greene, D. A., Chakrabarti, S., Lattimer, S. A., and Sima, A. A. (1987). Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol. J. Clin. Invest. 79:1479-1485.
15. Greene, D. A., Lattimer, S., Ulbrecht, J., and Carroll, P. (1985). Glucose-induced alterations in nerve metabolism: Current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8:290-299.
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
17. Hall, K. E., Liu, J., Sima, A. A., and Wiley, J. W. (2001). Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy. J. Europhysiol. 86:760-770.
18. Hall, K. E., Sima, A. A., and Wiley, J. W. (1995). Voltage-dependent calcium currents are enhanced in dorsal root ganglion neurones from the Bio Bred/Worchester diabetic rat. J. Physiol. 486:313-322.
19. Huang, T. J., Sayers, N. M., Fernyhough, P., and Verkhratsky, A. (2002). Diabetes-induced alterations in calcium homeostasis in sensory neurones of streptozotocin-diabetic rats are restricted to lumbar ganglia and are prevented by neurotrophin-3. Diabetologia 45:560-570.
20. Isaev, D., Gerber, G., Park, S. K., Chung, J. M., and Randic, M. (2000). Facilitation of NMDA-induced currents and Ca2+ transients in the rat substantia gelatinosa neurons after ligation of L5-L6 spinal nerves. Neuroreport 11:4055-4061.
21. 2+-ATPase activity in rats with streptozocin-induced diabetes: Association with reduced anesthetic requirements. Life Sci. 55:L359-L364.
22. Kamei, J., Taki, K., Ohsawa, M., and Hitosugi, H. (2000). Modulation of the formalin-induced nociceptive response by diabetes: Possible involvement of intracellular calcium. Brain Res. 862:257-261.
23. 2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat. Br. J. Pharmacol. 111:887-893.
24. 2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat. Br. J. Pharmacol. 108:780-785.
25. Kostyuk, E., Pronchuk, N., and Shmigol, A. (1995). Calcium signal prolongation in sensory neurones of mice with experimental diabetes. Neuroreport 6:1010-1012.
26. Kostyuk, E., Voitenko, N., Kruglikov, I., Shmigol, A., Shishkin, V., Efimov, A., and Kostyuk, P. (2001). Diabetes-induced changes in calcium homeostasis and the effects of calcium channel blockers in rat and mice nociceptive neurons. Diabetologia 44:1302-1309.
27. Kristian, T., Ouyang, Y., and Siesjo, B. K. (1996). Calcium-induced neuronal cell death in vivo and in vitro: Are the pathophysiologic mechanisms different? Adv. Neurol. 71:107-113.
28. Kristian, T., and Siesjo, B. K. (1996). Calcium-related damage in ischemia. Life Sci. 59:357-367.
29. Kruglikov, I., Gryshchenko, O., Shutov, L., Kostyuk, E., Kostyuk, P., and Voitenko, N. (2004). Diabetesinduced abnormalities in ER calcium mobilization in primary and secondary nociceptive neurons. Pflugers Arch. 448:395-401.
30. Landsberg, L., and Molitch, M. (2004). Diabetes and hypertension: Pathogenesis, prevention and treatment. Clin. Exp. Hypertens. 26:621-628.
31. Levy, J., Gavin, J. R., III, and Sowers, J. R. (1994). Diabetes mellitus: A disease of abnormal cellular calcium metabolism? Am. J. Med. 96:260-273.
32. Liu, C., and Hermann, T. E. (1978). Characterization of ionomycin as a calcium ionophore. J. Biol. Chem. 253:5892-5894.
33. Mancia, G., Omboni, S., Agabiti-Rosei, E., Casati, R., Fogari, R., Leonetti, G., Montemurro, G., Nami, R., Pessina, A. C., Pirrelli, A., and Zanchetti, A. (2000). Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients. J. Cardiovasc. Pharmacol. 35:926-931.
34. Mancia, G., Omboni, S., and Zanchetti, A. (1998). Clinical advantages of lipophilic dihydropyridines. Blood Press Suppl. 2:23-26.
35. Manschot, S. M., Biessels, G. J., Cameron, N. E., Cotter, M. A., Kamal, A., Kappelle, L. J., and Gispen, W. H. (2003a). Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats. Brain Res. 966:274-282.
36. Manschot, S. M., Gispen, W. H., Kappelle, L. J., and Biessels, G. J. (2003b). Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: Effects of treatment with an angiotensin converting enzyme inhibitor. Diabetes Metab. Res. Rev. 19:469-477.
37. Millan, M. J. (1999). The induction of pain: An integrative review. Prog. Neurobiol. 57:1-164.
38. Nag, S., and Kilty, D. W. (1997). Cerebrovascular changes in chronic hypertension. Protective effects of enalapril in rats. Stroke 28:1028-1034.
39. Neugebauer, V., Vanegas, H., Nebe, J., Rumenapp, P., and Schaible, H. G. (1996). Effects of N- and L-type calcium channel antagonists on the responses of nociceptive spinal cord neurons to mechanical stimulation of the normal and the inflamed knee joint. J. Neurophysiol. 76:3740-3749.
40. 2+ channel activation of ryanodine receptors. Neuron 40:53-63.
41. Richard, S. (2005). Vascular effects of calcium channel antagonists: New evidence. Drugs 65(Suppl 2):1-10.
42. Robertson, S., Cameron, N. E., and Cotter, M. A. (1992). The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia 35:1113-1117.
43. Roca-Cusachs, A., and Triposkiadis, F. (2005). Antihypertensive effect of manidipine. Drugs 65(Suppl 2):11-19.
44. Shibata, M., Ohkubo, T., Takahashi, H., and Inoki, R. (1989). Modified formalin test: Characteristic biphasic pain response. Pain 38:347-352.
45. 2+ exchange in vascular smooth muscle cells. Cell Calcium 10:125-134.
46. Stanfa, L. C., and Dickenson, A. H. (1999). The role of non-N-methyl-D-aspartate ionotropic glutamate receptors in the spinal transmission of nociception in normal animals and animals with carrageenan inflammation. Neuroscience 93:1391-1398.
47. Tuomilehto, J., Rastenyte, D., Birkenhager, W. H., Thijs, L., Antikainen, R., Bulpitt, C. J., Fletcher, A. E., Forette, F., Goldhaber, A., Palatini, P., Sarti, C., and Fagard, R. (1999). Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N. Engl. J. Med. 340:677-684.
48. 2+ transients in the presence of cyclothiazide in the rat substantia gelatinosa neurons. Cell Calcium 35:461-469.
49. Voitenko, N. V., Kostyuk, E. P., Kruglikov, I. A., and Kostyuk, P. G. (1999). Changes in calcium signalling in dorsal horn neurons in rats with streptozotocin-induced diabetes. Neuroscience 94:887-890.
50. Voitenko, N. V., Kruglikov, I. A., Kostyuk, E. P., and Kostyuk, P. G. (2000). Effect of streptozotocin-induced diabetes on the activity of calcium channels in rat dorsal horn neurons. Neuroscience 95:519-524.
51. Wenzel, R. R. (2005). Renal protection in hypertensive patients: Selection of antihypertensive therapy. Drugs 65(Suppl 2):29-39.
52. Zhou, S., Bonasera, L., and Carlton, S. M. (1996). Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. Neuroreport 7:895-900.